Literature DB >> 2001175

Production of infectious particles from defective human immunodeficiency virus type 1 (HIV-1)-producing cell clones by superinfection with infectious HIV-1.

M Yunoki1, K Maotani-Imai, H Kusuda, M Motoyama, S Miyake, H Imai, Y S Shin, S Kato, K Sano, C Morita.   

Abstract

A total of 81 cell clones persistently infected with the LAV-1 or HTLV-IIIB strain of human immunodeficiency virus type 1 (HIV-1) was isolated from cells which were obtained by serial passage of some proliferating MT-4 cells after a drastic cytolysis of most cells by HIV-1-infection. These cell clones were classified into 8 types (I to VIII) in terms of the expression of HIV-1 antigens, syncytium formation capacity, and reverse transcriptase activity and infectivity of virus particles in the culture fluid. Type I cell clones were producers of infectious HIV-1 particles, while types II to VIII cell clones did not produce infectious HIV-1 or were producers of uninfectious defective HIV-1 particles. Immunoprecipitation followed by SDS-polyacrylamide gel electrophoresis (PAGE) showed that the gag precursor protein in L-2 cell clone (type IV) was not cleaved to mature gag proteins, while the env precursor protein on L-3 cell clone (type III) was not cleaved to mature env protein. H-7 cell clone (type VIII) did not express any HIV-1 antigen. All these cell clones after the superinfection with infectious HIV-1 synthesized intact gag and env proteins, which were, at least in part, related to the HIV-1 genome persistently present in the cell clones before the superinfection, resulting in production of infectious HIV-1. For example, it was found that L-2 cell clone contained a single copy of the LAV-1 genome per haploid cell and produced doughnut-shaped particles. On the other hand, the cell clone isolated from the L-2 cell clone superinfected with infectious HTLV-IIIB contained the integrated HTLV-IIIB genome in addition to the LAV-1 genome present before the superinfection, and produced intact HIV-1 particles in addition to doughnut-shaped particles from a single cell. These results indicate that complementation and/or genetic recombination events in the superinfected cells may account for the production of infectious intact HIV-1 virions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2001175     DOI: 10.1007/bf01319238

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  31 in total

1.  Differential ability of human immunodeficiency virus isolates to productively infect human cells.

Authors:  L A Evans; T M McHugh; D P Stites; J A Levy
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

2.  Inhibition of HIV-1 replication and syncytium formation by synthetic CD4 peptides.

Authors:  Y Hayashi; K Ikuta; N Fujii; K Ezawa; S Kato
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

3.  Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.

Authors:  S Harada; Y Koyanagi; N Yamamoto
Journal:  Science       Date:  1985-08-09       Impact factor: 47.728

4.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

5.  Sensitive reverse transcriptase assay to detect and quantitate human immunodeficiency virus.

Authors:  M H Lee; K Sano; F E Morales; D T Imagawa
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

6.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Fluorographic detection of radioactivity in polyacrylamide gels with the water-soluble fluor, sodium salicylate.

Authors:  J P Chamberlain
Journal:  Anal Biochem       Date:  1979-09-15       Impact factor: 3.365

9.  AIDS-associated retroviruses (ARV) can productively infect other cells besides human T helper cells.

Authors:  J A Levy; J Shimabukuro; T McHugh; C Casavant; D Stites; L Oshiro
Journal:  Virology       Date:  1985-12       Impact factor: 3.616

10.  Inhibition of cleavage of Moloney murine leukemia virus gag and env coded precursor polyproteins by cerulenin.

Authors:  K Ikuta; R B Luftig
Journal:  Virology       Date:  1986-10-15       Impact factor: 3.616

View more
  8 in total

Review 1.  Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis.

Authors:  K Ikuta; S Suzuki; H Horikoshi; T Mukai; R B Luftig
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

2.  Protease-defective, gp120-containing human immunodeficiency virus type 1 particles induce apoptosis more efficiently than does wild-type virus or recombinant gp120 protein in healthy donor-derived peripheral blood T cells.

Authors:  M Kameoka; T Kimura; Y H Zheng; S Suzuki; K Fujinaga; R B Luftig; K Ikuta
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

3.  The majority of cells are superinfected in a cloned cell line that produces high levels of human immunodeficiency virus type 1 strain MN.

Authors:  D E Ott; S M Nigida; L E Henderson; L O Arthur
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

4.  Decoy approach using RNA-DNA chimera oligonucleotides to inhibit the regulatory function of human immunodeficiency virus type 1 Rev protein.

Authors:  T Nakaya; S Iwai; K Fujinaga; Y Sato; E Otsuka; K Ikuta
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

5.  Expression of human immunodeficiency virus type 1 reverse transcriptase in trans during virion release and after infection.

Authors:  M A Ansari-Lari; R A Gibbs
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

6.  Naturally occurring accessory gene mutations lead to persistent human immunodeficiency virus type 1 infection of CD4-positive T cells.

Authors:  M Kishi; Y H Zheng; M K Bahmani; K Tokunaga; H Takahashi; M Kakinuma; P K Lai; M Nonoyama; R B Luftig; K Ikuta
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 vif, vpr, and vpu mutants can produce persistently infected cells.

Authors:  Y Nishino; M Kishi; M Sumiya; K Ogawa; A Adachi; K Maotani-Imai; S Kato; K Hirai; K Ikuta
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

8.  Persistently human immunodeficiency virus type 1-infected T cell clone expressing only doubly spliced mRNA exhibits reduced cell surface CD4 expression.

Authors:  M Kishi; Y Nishino; K Ohki; T Kimura; K Ikuta
Journal:  Jpn J Cancer Res       Date:  1993-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.